CDKN2A and pancreatic neoplasm: In addition, studies have found that pancreatic cancer tumor growth and proliferation are related to CDK2/4/6 activation caused by CDKN2A deletion, and CDKN2A is closely related to the malignancy of esophageal squamous cell carcinoma [22].